Recent articles
Filters
Article types
Publication dates
Issues
Expanding the results
Sections
Access

151 - 175 of 176 Items

Review paper2022, jun 2

Radioligand therapy — personalized treatment for patients with neuroendocrine tumors

Agnieszka Kolasińska-Ćwikła

Vol 19, No 2 (2023)

Review paper

Oncol Clin Pract 2023;19(2):101-109.
Review paper2022, may 31

The usefulness of the QualityMetric Health Outcomes™ Scoring Software 5.0 for predicting the risk of depression in male partners of cancer patients

Marcin J. Jabłoński, Francisco Garcia-Torres, Paulina Zielińska, Alicja Bułat, Piotr Brandys, Marzena Samardakiewicz

Vol 18, No 4 (2022)

Review paper

Oncol Clin Pract 2022;18(4):235-239.
Review paper2022, may 31

Cisplatin — properties and clinical application

Anna Kopacz-Bednarska, Teodora Król

Vol 18, No 3 (2022)

Review paper

Oncol Clin Pract 2022;18(3):166-176.
Review paper2022, may 19

The rehabilitation of cancer patients and the role of nurses: a scoping review

Catarina Rodrigues, Bárbara Gomes, Carlos Albuquerque

Vol 18, No 3 (2022)

Review paper

Oncol Clin Pract 2022;18(3):147-165.
Research paper2022, may 19

Different MET gene alterations in lung adenocarcinoma patients

Paulina Terlecka, Paweł Krawczyk, Kamila Wojas-Krawczyk, Anna Grenda, Izabela Chmielewska, Robert Kieszko, Artur Bartczak, Janusz Milanowski

Vol 18, No 3 (2022)

Research paper

Oncol Clin Pract 2022;18(3):139-146.
Guidelines / Expert consensus2022, apr 26

Expert recommendation on diagnostic-therapeutic management in skin carcinomas

Piotr Rutkowski, Witold Owczarek, Dariusz Nejc, Arkadiusz Jeziorski, Wojciech M. Wysocki, Monika Słowińska, Monika Dudzisz-Śledź, Piotr Wiśniewski, Hanna Tchórzewska-Korba, Anna Szumera-Ciećkiewicz, Hanna Koseła-Paterczyk, Dorota Kiprian, Tomasz Świtaj, Joanna Narbutt, Leszek Królicki, Dawid Murawa, Marcin Zdziniecki, Marcin Ziętek, Adam Maciejczyk, Lidia Rudnicka

Vol 18, No 2 (2022)

Guidelines / Expert consensus

Oncol Clin Pract 2022;18(2):69-91.
Research paper2022, apr 26

Supportive activities in oncological wards during the COVID-19 pandemic: a qualitative study

Mahdieh Poodineh Moghadam, Ahmad Nasiri, Gholamhossein Mahmoudirad

Vol 19, No 1 (2023)

Research paper

Oncol Clin Pract 2023;19(1):1-8.
Case report2022, apr 6
Review paper2022, apr 6

Benefits of β-blockers in cancer treatment

Mohamad Arif, Mardiah Suci Hardianti, Nurina Tyagita, Azizah Hikma Safitri

Vol 19, No 2 (2023)

Review paper

Oncol Clin Pract 2023;19(2):90-100.
Case report2022, mar 31

Stevens-Johnson syndrome in breast cancer patient treated with ribociclib

Adam Kowalczyk, Barbara Radecka

Vol 19, No 1 (2023)

Case report

Oncol Clin Pract 2023;19(1):59-62.
Case report2022, mar 31

Resistance to neoadjuvant chemotherapy in breast cancer with proven intratumoral heterogeneity: a clinical case

Vasil D. Nanev, Silvia V. Naneva, Angel D. Yordanov, Strahil A. Strashilov, Ivan N. Ivanov

Vol 18, No 2 (2022)

Case report

Oncol Clin Pract 2022;18(2):134-138.
Review paper2022, mar 30

Evolution of prostate cancer therapy. Part 1

Paweł M. Potocki, Piotr J. Wysocki

Vol 18, No 3 (2022)

Review paper

Oncol Clin Pract 2022;18(3):177-188.
Review paper2022, mar 24

What is new about germ cell ovarian tumors?

Izabela Pilarska, Kinga Grabska, Marta Fudalej, Andrzej Deptała, Anna Badowska-Kozakiewicz

Vol 18, No 2 (2022)

Review paper

Oncol Clin Pract 2022;18(2):115-118.
Research paper2022, mar 24

Grief reactions of family members after the death of cancer patients: a phenomenological study

Mahnaz Ghaljeh, Marjan Mardani-Hamooleh, Nasrin Rezaee

Vol 18, No 2 (2022)

Research paper

Oncol Clin Pract 2022;18(2):98-103.
Review paper2022, mar 17

Immune checkpoint inhibitors in the first-line treatment of metastatic small-cell lung cancer

Magdalena Knetki-Wróblewska, Dariusz M. Kowalski, Maciej Krzakowski

Vol 18, No 2 (2022)

Review paper

Oncol Clin Pract 2022;18(2):104-114.
Case report2022, mar 8

Immunotherapy with pembrolizumab in a patient with advanced non-small-cell lung cancer with high PD-L1 expression and MET exon 14 splice site mutation

Paulina Terlecka, Paweł Krawczyk, Anna Grenda, Izabela Chmielewska, Janusz Milanowski

Vol 19, No 1 (2023)

Case report

Oncol Clin Pract 2023;19(1):63-68.
Research paper2022, mar 7

Microwave ablation of colorectal cancer lung metastases — the first experience in Poland

Grzegorz Rosiak, Maciej Krzakowski, Krzysztof Milczarek, Dariusz Konecki, Olgierd Rowiński

Vol 19, No 2 (2023)

Research paper

Oncol Clin Pract 2023;19(2):86-89.
Commentary2022, mar 3

Commentary to Targeted therapy for advanced cutaneous melanoma

Piotr Rutkowski, Katarzyna Kozak

Vol 18, No 3 (2022)

Commentary

Oncol Clin Pract 2022;18(3):208-209.
Review paper2022, feb 22

Targeted therapy for advanced cutaneous melanoma

Alice Indini, Fausto Roila, Rossana Gueli, Francesco Grossi, Mario Mandalà

Vol 18, No 3 (2022)

Review paper

Oncol Clin Pract 2022;18(3):197-207.
Review paper2022, feb 3
Guidelines / Expert consensus2022, jan 10

Thoracic neoplasms

Maciej Krzakowski, Jacek Jassem, Adam Antczak, Katarzyna Błasińska, Joanna Chorostowska-Wynimko, Rafał Dziadziuszko, Maciej Głogowski, Tomasz Grodzki, Dariusz Kowalski, Rafał Krenke, Renata Langfort, Włodzimierz Olszewski, Tadeusz Orłowski, Paweł Śliwiński, Andrzej Tysarowski, Witold Rzyman, Marek Woźniewski

Vol 18, No 1 (2022)

Guidelines / Expert consensus

Oncol Clin Pract 2022;18(1):1-39.
Review paper2022, jan 5

EORTC QLQ-C30 and EORTC QLQ-PR25 — tools for assessing the quality of life of men suffering from prostate cancer

Tomasz Jurys, Mikołaj Smółka, Monika Dzierzawa-Kloza, Michalina Stepanik, Bartłomiej Burzyński

Vol 18, No 1 (2022)

Review paper

Oncol Clin Pract 2022;18(1):61-67.